Reinforcing cancer immunotherapy with engineered porous hollow mycobacterium tuberculosis loaded with tumor neoantigens
Background Enhancing antigen cross-presentation is essential for the development of a tumor neoantigen vaccine. One approach is to stimulate antigen-presenting cells (APCs) to uptake neoantigens. Mycobacterium tuberculosis (MTb) contains pathogen-associated molecular patterns (PAMPs) recognized by A...
Saved in:
Main Authors: | Jie Jiang, Feng-Ying Huang, Shu-Zhen Dai, Guang-Hong Tan, Ming-Hui Chen, Hengyu Chen, Wu-Ping Zheng, Ri-Hong Wu, Weijing Xie |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2025-02-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Online Access: | https://jitc.bmj.com/content/13/2/e010150.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Neoantigen immunotherapy: a novel treatment for bladder cancer
by: Ruiyang Lv, et al.
Published: (2025-01-01) -
Unveiling immunogenic characteristics and neoantigens in endometrial cancer with POLE hotspot mutations for improved immunotherapy
by: Jian Huang, et al.
Published: (2025-01-01) -
Repurposing Amlexanox to treat head and neck cancers: Increasing neoantigen expression to facilitate immunotherapy
by: Saravanan Sekaran, et al.
Published: (2024-06-01) -
Identification of Nontuberculous Mycobacterium and Mycobacterium tuberculosis Complex in Sputum Patients with Suspected Tuberculosis
by: Fanny Indriyani Biyang, et al.
Published: (2024-12-01) -
Evaluation of the cross-immunity between Mycobacterium tuberculosis and Mycobacterium abscessus in vitro
by: Da Xu, et al.
Published: (2025-01-01)